SUMMARY Approximately 70% of patients with dermatomyositis have evidence of cardiac damage; in one third of cases this affects principally or solely the conduction tissue. In infants similar histological lesions have been associated with a maternal autoantibody, anti-Ro, that crosses the placenta and produces congenital heart block. Anti-Ro antibody was detected in a fatal case of dermatomyositis with lesions of the conduction system. Dermatomyositis (polymyositis, when there is no associated rash) is an inflammatory myopathy of unknown aetiology that affects the heart in about 70% of cases. Heart failure is the third leading cause of death in the disorder.' In one third of those affected the conduction system is principally or solely damaged. ' 2 A specific maternal autoantibody, anti-Ro, that crosses the placenta and damages the fetal heart produces the same heart injury in infants.3 Because there are numerous immunological abnormalities in dermatomyositis, including the presence of various autoantibodies,4 we examined the serum of a case of dermatomyositis with heart block for anti-Ro antibody. This autoantibody was detected on two occasions before she died of cardiac failure.
Dermatomyositis (polymyositis, when there is no associated rash) is an inflammatory myopathy of unknown aetiology that affects the heart in about 70% of cases. Heart failure is the third leading cause of death in the disorder.' In one third of those affected the conduction system is principally or solely damaged. ' 2 A specific maternal autoantibody, anti-Ro, that crosses the placenta and damages the fetal heart produces the same heart injury in infants. 3 Because there are numerous immunological abnormalities in dermatomyositis, including the presence of various autoantibodies,4 we examined the serum of a case of dermatomyositis with heart block for anti-Ro antibody. This autoantibody was detected on two occasions before she died of cardiac failure. compared with a normal healthy control.
Non-specific deposition of IgG was noted in necrotic myocardial, Purkinje, and skeletal muscle fibres. On direct immunofluorescence the anti-Ro antibody produced bright, coarsely granular, intracytoplasmic staining of myocardial, Purkinje, and skeletal muscle fibres. Conduction tissue did not stain differently from the other types of muscle.
In the skeletal and cardiac inflammatory lesions that we examined macrophages formed 50% of the inflammatory cells in skeletal muscle and 30% of those in the myocardium, while T lymphocytes made up 30% of inflammatory cells in muscle and 60% of those in the myocardium. B lymphocytes accounted for 20% and 10% respectively, no K cells were found in either tissue, and the helper and suppressor:cytotoxic ratios were 4:1 (skeletal muscle) and 3:1 (myocardium).
Discussion
This patient had featues typical of dermatomyositis and she developed myocarditis with severe inflammation and fibrosis of the conduction system. She died of cardiac failure. An electrocardiogram showed right bundle branch block but at necropsy we found widespread damage to both the sinoatrial and atrioventricular nodes together with mild focal myocardial inflammation. We detected a specific autoantibody, anti-Ro, in her serum on two occasions and we suggest that this antibody had a pathogenetic effect on her heart tissue.
There is very good evidence that anti-Ro antibody is involved in the lesions of congenital heart block3: it is found in more than 80% of mothers and affected infants, it is usually the only autoantibody found in both, it disappears from the infant's serum before six months of age, and, most importantly, maternal immunoglobulins and complement are deposited at the site of injury in the affected hearts.'0 The histological lesions reported-partial or complete replacement fibrosis of the atrioventricular node and bundles with a mild generalised myocarditis3-are similar to those reported in patients with polymyositis.' A comprehensive recent review of patients with polymyositis emphasised how characteristic the damage to conduction tissue is.2 The lesions are related to the length and severity of the disease course but they can progress even when the skeletal muscle inflammation has remitted, and the 482 Behan, Aitchison, Behan patients may die quite unexpectedly. Because cardiac involvement is unrecognised clinically in one third of cases, the identification of a possible serological marker is important.
One of the puzzling features of the anti-Ro seropositive mothers who deliver infants with congential heart block is that their own hearts are apparently unaffected.3 In dermatomyositis numerous other immunological abnormalities have been reported4 and it may be that these predispose the cases to the pathogenetic effect of the antibody. In our patient, a basic immunoregulatory defect was suggested by the finding of a severe decrease in peripheral blood suppressor lymphocytes and the demonstration of an inflammatory infiltrate including T and B lymphocytes and macrophages.
The cause of heart block is unknown in most cases but a minority do have collagen diseases.'2 The occurrence of anti-Ro antibody in a proportion of patients with collagen disorders3 and the presence of high concentrations of heart muscle" are therefore of great importance. We suggest that anti-Ro antibody played a role in producing immunological injury to the heart in our case and that this antibody should be sought in other patients with conduction disorders and connective tissue diseases.
